Skip to main content
Bloomberg Logo
Bloomberg

Articles by Bloomberg

Bloomberg

Google Bets on New Chips to Boost AI Results, Challenging Nvidia

In a matter of months, Google's AI chips have become one of the hottest commodities in the tech sector. Leading artificial intelligence developers, including some of the firm's biggest rivals, are stocking up on them. Now, the Alphabet Inc.-owned company aims to build on its momentum with the likely introduction of new chips dedicated to inference, or running AI models after they've been trained. With this push, Google is poised to further challenge market leader Nvidia Corp. in a fast-growing category for semiconductors that's fueled by surging adoption of AI software. Bloomberg News AI Infrastructure Reporter Dina Bass joins Bloomberg Businessweek Daily to discuss. She speaks with Carol Massar and Tim Stenovec.

Read more
Bloomberg

Compass Pathways CEO on Trump's Order to Expand Psychedelics Research

Shares of companies involved in psychedelic-tied therapies surged Monday after President Donald Trump signed an executive order to expedite research and access. US-traded shares of Compass Pathways spiked as much as 53% while AtaiBeckley surged by 37%. GH Research jumped 34% and Definium Therapeutics rallied 16%. The AdvisorShares Psychedelics ETF (PSIL) also climbed as much as 20% touching its highest intraday level since July 2023. The new order directs the US Food and Drug Administration to issue expedited review vouchers to psychedelics with a so-called breakthrough designation, shortening the review time to one to two months from six to ten months. AtaiBeckley, Definium and Compass Pathways all have therapies with breakthrough status. Compass Pathways CEO Kabir Nath joins Bloomberg Businessweek Daily to discuss. He speaks with Carol Massar and Tim Stenovec.

Read more